Publications by authors named "Nicolas Staedler"

Claim this Profile
N
Neoadjuvant PD-1 and LAG-3-targeting bispecific antibody and other immune checkpoint inhibitor combinations in resectable melanoma: the randomized phase 1b/2 Morpheus-Melanoma trial.
Georgina V Long, Nitya Nair, Daniel Marbach, Richard A Scolyer, Sabine Wilson, Nicolas Staedler

Nat Med· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of conserved immune-related adverse event risk factors and clinical outcomes in a pan-immunotherapy data mart.
David F Lamparter, Virginia C Schmid, Rajat Mohindra, Vaios Karanikas, Tony Kam-Thong, Nicolas Staedler

J Immunother Cancer· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune modulation in solid tumors: a phase 1b study of RO6870810 (BET inhibitor) and atezolizumab (PD-L1 inhibitor).
Daniel Marbach, Jurriaan Brouer-Visser, Laura Brennan, Sabine Wilson, Iakov I Davydov, Nicolas Staedler

BMC Cancer· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor-agnostic transcriptome-based classifier identifies spatial infiltration patterns of CD8+T cells in the tumor microenvironment and predicts clinical outcome in early-phase and late-phase clinical trials.
Andreas Roller, Iakov I Davydov, Petra C Schwalie, Martha L Serrano-Serrano, Astrid Heller, Nicolas Staedler

J Immunother Cancer· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-dimensional single-cell proteomics analysis identifies immune checkpoint signatures and therapeutic targets in ulcerative colitis.
Sebastian Fuchs, Nadia Sawas, Nicolas Staedler, David A Schubert, Annalisa D'Andrea

Eur J Immunol· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis